Open Access

Recurrence‑associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma

  • Authors:
    • Wentao Yu
    • Guanyuan Liu
    • Chongdong Liu
    • Zhenyu Zhang
  • View Affiliations

  • Published online on: July 5, 2018     https://doi.org/10.3892/ol.2018.9082
  • Pages: 3430-3438
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to identify which patients with adenomyoma would benefit from sparing the uterus and which patients should undergo a hysterectomy to avoid secondary surgery. Patients with pathology‑proven adenomyoma admitted to Beijing Chao‑Yang Hospital between November 2005 and November 2015 were retrospectively reviewed. Relief and reappearance of dysmenorrhea following laparoscopic adenomyomectomy were evaluated. All 49 patients (mean age, 40.6±5.2 years; age range, 26‑51 years) presented with severe dysmenorrhea prior to surgery. Dysmenorrhea was identified to be relieved in 83.7% (41/49) of patients at the 6‑month follow‑up. No factors were revealed to have a significant effect on the surgical outcome. The median follow‑up period was 4.6 (1‑11) years; and 24.5% (12/49) of patients experienced recurrence of dysmenorrhea. Multivariate analysis identified preoperative serum cancer antigen 125 (CA 125) levels [hazard ratio (HR), 2.356; 95% confidence interval (CI), 1.271‑3.570; P=0.011], postoperative gonadotropin‑releasing hormone agonist (GnRH‑a) treatment (HR, 0.540; 95% CI, 0.241‑0.873; P=0.017) and accompanying endometriosis (HR, 2.182; 95% CI, 1.556‑3.031; P=0.003) as independent risk factors for relapse. Laparoscopic adenomyomectomy is effective for alleviating dysmenorrhea in patients with adenomyoma. Patients with lower preoperative serum CA 125 levels without accompanying endometriosis benefited greater from adenomyomectomy compared with all other patients. Postoperative GnRH‑a treatment strengthens therapeutic effects.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu W, Liu G, Liu C and Zhang Z: Recurrence‑associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma. Oncol Lett 16: 3430-3438, 2018
APA
Yu, W., Liu, G., Liu, C., & Zhang, Z. (2018). Recurrence‑associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma. Oncology Letters, 16, 3430-3438. https://doi.org/10.3892/ol.2018.9082
MLA
Yu, W., Liu, G., Liu, C., Zhang, Z."Recurrence‑associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma". Oncology Letters 16.3 (2018): 3430-3438.
Chicago
Yu, W., Liu, G., Liu, C., Zhang, Z."Recurrence‑associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma". Oncology Letters 16, no. 3 (2018): 3430-3438. https://doi.org/10.3892/ol.2018.9082